Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.14
+0.24 (1.51%)
Jun 16, 2026, 10:12 AM EDT - Market open

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
85294090249307
Market Cap Growth
543.16%-27.23%-55.93%-63.63%-18.90%-
Enterprise Value
37.46-25.56-25.51-19.1280.15131.19
Last Close Price
16.145.497.6819.1252.5676.32
PS Ratio
98.0333.8062.66---
PB Ratio
1.670.500.650.851.471.75
EV/Sales Ratio
43.67-29.79-40.11---
EV/EBITDA Ratio
-0.780.420.24--
EV/EBIT Ratio
-0.770.420.24--
EV/FCF Ratio
-0.860.520.32--
Debt / Equity Ratio
0.000.0000.000.000
Net Debt / Equity Ratio
-0.93-0.94-1.06-1.03-0.99-1.00
Net Debt / EBITDA Ratio
1.461.661.081.392.493.85
Net Debt / FCF Ratio
1.691.831.331.822.943.82
Asset Turnover
0.010.010.01000
Quick Ratio
11.3012.9610.5011.8715.7326.76
Current Ratio
12.9214.5010.8712.3916.7127.61
Return on Equity (ROE)
-14.44%-15.01%-68.85%-54.13%-38.65%-30.17%
Return on Assets (ROA)
-55.04%-50.72%-65.85%-53.32%-37.44%-28.17%
Return on Invested Capital (ROIC)
-887.00%-1355.92%-5217.42%-7274.84%-5573.40%-4772.40%
Return on Capital Employed (ROCE)
-59.29%-55.15%-71.92%-57.19%-39.32%-29.29%
Buyback Yield / Dilution
-1.50%-3.42%-7.66%-27.11%-24.70%-46.76%
Total Shareholder Return
-1.50%-3.42%-7.66%-27.11%-24.70%-46.76%
SEC Filings: 10-K · 10-Q